🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

C. Chris Huang

Bristol-Myers Squibb (United States)

ORCID: 0000-0002-1116-2756

MedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation”.

Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation

Nature Communications(2024)10.1038/s41467-024-50830-y

N/A

0DataRank · unranked

17 citations

Kerstin Wenzl, C. Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew J. Maurer +23 more

Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

Blood Cancer Journal(2024)10.1038/s41408-024-01080-0

N/A

0DataRank · unranked

12 citations

Matthew E. Stokes, Joseph P. Novak, Allison M. Bock, Sana Khan, Melissa A. Hopper +25 more

Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01326-5

N/A

0DataRank · unranked

7 citations

Kerstin Wenzl, Joseph P. Novak, Matthew E. Stokes, Melissa A. Hopper, Abigail R. Dropik +17 more